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Serologic Evidence 
of Human 
Granulocytic 
Ehrlichiosis, Greece
To the Editor: Human granulo-
cytic ehrlichiosis (HGE), a tickborne
infectious disease, was first described
in 1994 (1). Several cases have been
reported in the United States; reports
of acute cases in Europe have been
rare, although European serosurveys
of the prevalence of antibodies to the
HGE agent have been conducted (2–
4). No similar serosurvey has been
conducted in Greece, although Ixodes
ricinus, thought to be the principal tick
vector in Europe (5), is present in
northern Greece (6). Lyme disease,
which is transmitted by the same tick,
has never been reported, and the sero-
prevalence of Lyme borreliosis in
Greece is very low (7).
We examined sera of 300 persons
(100 men and 200 women) ages 15–78
years (mean age ± standard deviation
52.7±18.0 years), which were col-
lected at six county hospitals in north-
ern Greece and sent to our laboratory
from April to October 2000. The par-
ticipants were mostly farmers, all of
whom lived in rural areas of northern
Greece. All participants were healthy
and had been hospitalized for routine
blood tests. Each patient completed a
questionnaire about medical history.
The selected patients had no known
history of rickettsiosis and reported no
febrile or influenza-like illness during
the past 6 months. Each participant
provided oral consent for the serum to
be used for detecting antibodies
against several infectious agents
related to zoonoses. The following
information was recorded for each
participant: age, sex, occupation, and
area of residence. 
Serum samples were tested by
indirect immunofluorescence (IFA)
with commercially available antigen
(Focus Technologies, Cypress, Cali-
fornia), which uses HGE-1–infected
HL60 cells. Titers >64 were consid-
ered positive. All sera were also tested
for  Rickettsia conorii,  R. typhi,
Coxiella burneti, and Ehrlichia chaf-
feensis by IFA and for Borrelia burg-
dorferi by enzyme-linked immuno-
sorbent assay and Western blot. Sera
that reacted positively to more than
one of these agents were excluded.
Biostatistical analysis was performed
by using the statistical package SPSS
for Windows 10.0.1 (Standard version,
SPSS Inc., Chicago, IL).
The overall prevalence of antibod-
ies to the HGE agent was 7.3% (8.0%
for men and 7.0% for women). No sta-
tistically significant differences were
observed in the prevalence of antibod-
ies in the six prefecture hospitals. Par-
ticipants had no statistically sig-
nificant differences in sex or age.
Antibody titers to HGE were low (of
22 positive sera, 12 had titers >64 and
10 had titers >128).
Several serosurveys of the preva-
lence of antibodies to the HGE agent
have been conducted across Europe in
both healthy persons and patients with
suspected or confirmed Lyme borreli-
osis (2,3,8). Since cases of B. burgdor-
feri infection are rare or nonexistent in
Greece and the seroprevalence of
Lyme borreliosis is very low, we
selected as participants 300 healthy
farmers who lived in rural areas.
These persons compose a group at
high risk for exposure to tick bites and
therefore to I. ricinus. Our prevalence
is higher than those observed in Bul-
garia (2.9%) and Germany (1.9%)
(2,3). This finding could be attributed
to the fact that the prevalence in these
countries was based on blood donors,
unlike our survey. However, our prev-
alence is substantially lower than that
in Slovenia, where 15.4% of the
examined population had detectable
antibodies to the HGE agent and sev-
eral cases of HE have been confirmed
(4). Our observation that no signifi-
cant differences occurred in the preva-
lence of antibodies to the HGE agent
in the six prefectures studied could be
explained by the fact that these dis-
tricts are small, with little variation in
environmental and climatic condi-
tions. Even though the antibody titers
to the HGE agent were low in our sur-
vey, they suggest infection at an unde-
termined time (9). Seven of our sera
were antibody positive to both the
HGE agent and at least one other rick-
ettsial agent or B. burgdorferi. This
fact, which has been observed else-
where (9), may result from coinfection
or crossreaction. These sera were
excluded. Our data suggest the possi-
bility that HGE cases exist in Greece.
Since such cases have been not been
reported to date, they are likely under-
diagnosed. Further research is needed
to clarify the presence of the HGE
agent in Greece.
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Hantavirus Infection 
with Marked Sinus 
Bradycardia, Taiwan
To the Editor: Hantaviruses are
enveloped RNA viruses belonging to
the family Bunyaviridae  (1,2), for
which a number of species have been
identified, including the Hantaan,
Seoul, Puumala, Dobrava-Belgrade,
and Sin Nombre viruses (1,2). Each
hantavirus is associated with a specific
rodent reservoir (1,2). Hantaan virus,
found throughout northeastern Asia,
causes a life-threatening illness known
as hemorrhagic fever with renal syn-
drome (HFRS). Main symptoms and
signs of HFRS are fever, myalgia,
severe vascular leakage with ascites
and retroperitoneal edema and pain
(abdominal, loin, or headache), shock,
acute renal failure, proteinuria and
hematuria, thrombocytopenia, and
bleeding complications (3). Seoul
virus, found worldwide, and Puumala
virus, found in Scandinavia and East-
ern Europe, cause mild forms of
HFRS. Sin Nombre virus, found in the
United States, causes hantavirus pul-
monary syndrome, which is character-
ized by increased pulmonary capillary
permeability and pulmonary edema
and can progress to severe respiratory
distress syndrome and shock as a
result of low cardiac output (4,5).
Despite the fact that HFRS is fre-
quently reported in People’s Republic
of China, no indigenous cases of
HFRS have been reported in Taiwan.
Previous serologic studies found that
the Seoul strain is endemic in the areas
of Taiwan and two isolated islands
nearby, Kinmen and Matzu; in con-
trast, in the People’s Republic of
China, the Hantaan and Seoul strains
concurrently predominate (6,7).
Our patient, a 38-year-old man,
had onset of sore throat, headache,
cough, myalgia, and intermittent fever
(up to 38.3°C) on February 2, 2001. A
resident of Matzu for more than 30
years, he had traveled to the People’s
Republic of China 3 months before the
symptoms began. Laboratory tests at a
local hospital showed thrombocytope-
nia (58,000/mL) and leukopenia
(3,800/mL). Because his symptoms
persisted, he was transferred to the
National Taiwan University Hospital
on February 7, 2001. Initial tests there
showed a temperature of 36.4°C, heart
rate 74 beats/min, and respiratory rate
18/min; there was no skin rash. The
rest of the physical examination was
normal. He had a platelet count
73,000/µL; leukocytes 5,670/µL with
59.1% segments, 19.8% lymphocytes,
and 18.2% monocytes; urea nitrogen
7.4 mg/dL; and creatinine 0.94 mg/dL.
Urinalysis showed proteinuria (300
mg/dL). His chest radiography was
normal. Abdominal ultrasound
showed a fatty liver.
After admission, the patient’s lab-
oratory values gradually improved and
his proteinuria subsided. He had no
fever. On February 10, 2001, he had
marked sinus bradycardia (as low as
33 beats/min) and became fatigued.
His blood pressure was 120–130/70–
80 mmHg. No abnormal serum elec-
trolytes, urea nitrogen, creatinine, cre-
atine kinase, and troponin-I were
noted. Echocardiogram showed nor-
mal atrium and ventricle size, good
left ventricle contractility, and small
amount of pericardial effusion. His
heart rate gradually increased. He was
discharged on February 15, 2001,
without event. 
A substantial increase of serum
immunofluorescent immunoglobulin
(Ig) G titers (1:640 on February 6;
1:5120 on February 19, 2001) and
positive IgM titers of 1:80 against
hantavirus antigen (Seoul type) con-
firmed that this virus was responsible
for the illness.
A few reports of hantavirus infec-
tion with cardiac involvement have
been published. A case report by Chun
and Godfrey showed right atrium dila-
tion with diffuse atrial hemorrhage,
interstitial edema, and vascular con-
gestion without surrounding myocar-
dial fibers and conduction system
involvement in a 19-year-old soldier
who died from epidemic (Korean)
hemorrhagic fever, sinus tachycardia,
paroxysmal supraventricular tachycar-
dia, and congestive heart failure (8).
Marked sinus bradycardia (as low as
34 beats/min) in a patient with a
severe form of hemorrhagic fever with
renal syndrome (acute renal failure)
has been reported (9). However, this
finding was not observed in patients
with mild cases of the disease.
The possibility that our patient
acquired the infection during his travel
to the People’s Republic of China 3
months earlier is extremely low
because of the length of the incubation
period (typical incubation period 4–28
days) (10) and the different hantavirus
strains prevalent in the People’s
Republic of China (6). Although viral
genetic sequence data from the patient
and rodents in Matzu were not avail-
able in this study, our patient was
infected with the Seoul strain, which is
highly seroprevalent in rodents in
Matzu (6,7).  
In summary, this case was probably
the first indigenous case of hantavirus
infection in Taiwan. Its characteristics
suggest that marked sinus bradycardia
should be included as a protean mani-
festation of hantavirus.
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